The funds will be used for pursuing commercial launches in Europe and preparing for U.S. Food and Drug Administration clearance and commercialization in the United States and other global markets. Existing Medrobotics shareholders participated in the financing.
Medrobotics is a privately-held company that manufactures and markets the Flex System, a computer-assisted flexible endoscopic platform, which has received the CE Mark but is not currently cleared for sale in the U.S.
More articles on gastroenterology:
Capsule, surgical endoscope market to grow 13.8% through 2018
Dr. David Rubin named UChicago Joseph B. Kirsner Professor of Medicine
Dr. Nitesh Ratnakar elected West Virginia ACG governor
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.